SCHEMBL6430588

SCHEMBL6430588

FC(F)(F)c1ccc(Nc2nc(Cc3ncc[nH]3)nc3cc(-c4ncccc4Cl)cnc23)cc1

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 20/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4976273 0.85 TRPV1 (0.64) TRPV1
SCHEMBL4973325 0.83 TRPV1 (0.65) TRPV1
SCHEMBL4971744 0.80 TRPV1 (0.50) TRPV1
SCHEMBL6430978 0.80 TRPV1 (0.75) TRPV1
SCHEMBL14283447 0.77 TRPV1 (0.69) TRPV1
SCHEMBL4978375 0.77 TRPV1 (0.69) TRPV1
SCHEMBL14283340 0.77 TRPV1 (0.69) TRPV1
SCHEMBL4973571 0.76 TRPV1 (0.78) TRPV1
SCHEMBL4973093 0.75 TRPV1 (0.54) TRPV1
SCHEMBL14337675 0.74 TRPV1 (0.67) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581225-A1 COMBINATION THERAPY FOR THE TREATMENT OF PAIN NEUROGEN CORPORATION (US) 2005-10-05 EP disclosed
WO-2004054582-A1 COMBINATION THERAPY FOR THE TREATMENT OF PAIN NEUROGEN CORPORATION (US) 2004-07-01 WO disclosed